Matteo Dalla Chiesa

Oxaliplatin-induced hemolytic anemia during adjuvant treatment of a patient with colon cancer: a case report

Sebastiano Buti, Matteo Riccò, Matteo Dalla Chiesa et al. · Anti-Cancer Drugs · 2007 · 36 citations

Surgical Oncology, Immunology, Adjuvant Chemotherapy +17

Phase III, randomised, multicentre trial of maintenance immunotherapy with low-dose interleukin-2 and interferon-α for metastatic renal cell cancer

Rodolfo Passalacqua, Carlo Buzio, Sebastiano Buti et al. · Cancer Immunology Immunotherapy · 2009 · 22 citations · Full text

Urology, Maintenance Immunotherapy, Cancer Immunosurveillance +8

Tamoxifen vs Tamoxifen plus 13-cis-retinoic acid vs Tamoxifen plus Interferon alpha-2a as first-line endocrine treatments in advanced breast cancer: updated results of a phase II, prospective, randomised multicentre trial.

Matteo Dalla Chiesa, Rodolfo Passalacqua, Maria Michiara et al. · PubMed · 2007 · 22 citations

Prospective, Multicenter, Randomized Trial of a New Organizational Modality for Providing Information and Support to Cancer Patients

Rodolfo Passalacqua, Caterina Caminiti, Francesco Campione et al. · Journal of Clinical Oncology · 2009 · 20 citations · Full text

Dose-dense Chemotherapy in Metastatic Gastric Cancer with a Modified Docetaxel-Cisplatin-5-Fluorouracil Regimen

Gianluca Tomasello, Matteo Dalla Chiesa, Sebastiano Buti et al. · Tumori Journal · 2010 · 11 citations